CEL-SCI Corporation (CVM)
NYSEAMERICAN: CVM · Real-Time Price · USD
0.2175
-0.0129 (-5.60%)
Apr 1, 2025, 9:30 AM EST - Market open

CEL-SCI Market Cap

CEL-SCI has a market cap or net worth of $16.79 million as of April 1, 2025. Its market cap has decreased by -84.11% in one year.

Market Cap
16.79M
Enterprise Value
23.84M
1-Year Change
-84.11%
Ranking
Category
Stock Price
$0.22

Market Cap Chart

Since January 29, 2003, CEL-SCI's market cap has decreased from $2.50B to $16.79M, a decrease of -99.33%. That is a compound annual growth rate of -20.19%.

History

DateMarket Cap% Change
Mar 31, 202517.80M-27.64%
Dec 31, 202424.60M-81.90%
Dec 29, 2023135.90M32.46%
Dec 30, 2022102.60M-66.58%
Dec 31, 2021307.00M-33.78%
Dec 31, 2020463.60M43.22%
Dec 31, 2019323.70M297.18%
Dec 31, 201881.50M226.00%
Dec 29, 201725.00M96.85%
Dec 30, 201612.70M-73.60%
Dec 31, 201548.10M-9.42%
Dec 31, 201453.10M80.61%
Dec 31, 201329.40M-60.16%
Dec 31, 201273.80M10.81%
Dec 30, 201166.60M-60.45%
Dec 31, 2010168.40M25.11%
Dec 31, 2009134.60M300.60%
Dec 31, 200833.60M-42.37%
Dec 31, 200758.30M27.85%
Dec 29, 200645.60M25.27%
Dec 30, 200536.40M-16.13%
Dec 31, 200443.40M-98.26%
Jan 29, 20032.50B-
View and export this data all the way back to 2003. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 741.66B
UnitedHealth Group 479.08B
Johnson & Johnson 399.65B
AbbVie 370.64B
Novo Nordisk 302.16B
Abbott Laboratories 230.06B
Merck & Co. 226.74B
AstraZeneca 225.46B
Market Cap Rankings